GRRMF
Price
$51.41
Change
-$0.24 (-0.46%)
Updated
Aug 5 closing price
Capitalization
1.75B
IDTA
Price
$0.20
Change
-$0.01 (-4.76%)
Updated
Aug 26 closing price
Capitalization
809.12K
Interact to see
Advertisement

GRRMF vs IDTA

Header iconGRRMF vs IDTA Comparison
Open Charts GRRMF vs IDTABanner chart's image
Gerresheimer AG
Price$51.41
Change-$0.24 (-0.46%)
Volume$100
Capitalization1.75B
Identa
Price$0.20
Change-$0.01 (-4.76%)
Volume$44.28K
Capitalization809.12K
GRRMF vs IDTA Comparison Chart in %
Loading...
GRRMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRRMF vs. IDTA commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRRMF is a Buy and IDTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (GRRMF: $51.41 vs. IDTA: $0.20)
Brand notoriety: GRRMF and IDTA are both not notable
GRRMF represents the Pharmaceuticals: Other, while IDTA is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GRRMF: 38% vs. IDTA: 522%
Market capitalization -- GRRMF: $1.75B vs. IDTA: $809.12K
GRRMF [@Pharmaceuticals: Other] is valued at $1.75B. IDTA’s [@Medical Specialties] market capitalization is $809.12K. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B. The average market capitalization across the [@Medical Specialties] industry is $10.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRRMF’s FA Score shows that 0 FA rating(s) are green whileIDTA’s FA Score has 1 green FA rating(s).

  • GRRMF’s FA Score: 0 green, 5 red.
  • IDTA’s FA Score: 1 green, 4 red.
According to our system of comparison, IDTA is a better buy in the long-term than GRRMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRRMF’s TA Score shows that 5 TA indicator(s) are bullish while IDTA’s TA Score has 3 bullish TA indicator(s).

  • GRRMF’s TA Score: 5 bullish, 0 bearish.
  • IDTA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GRRMF is a better buy in the short-term than IDTA.

Price Growth

GRRMF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while IDTA (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.57%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was +18.37%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.47%. For the same industry, the average monthly price growth was +7.02%, and the average quarterly price growth was +11.93%.

Industries' Descriptions

@Pharmaceuticals: Other (-1.57% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.47% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GRRMF($1.75B) has a higher market cap than IDTA($809K). GRRMF has higher P/E ratio than IDTA: GRRMF (24.15) vs IDTA (1.94). GRRMF YTD gains are higher at: -26.294 vs. IDTA (-46.553). GRRMF has higher annual earnings (EBITDA): 422M vs. IDTA (517K). GRRMF has more cash in the bank: 203M vs. IDTA (203K). IDTA has less debt than GRRMF: IDTA (650K) vs GRRMF (2.21B). GRRMF has higher revenues than IDTA: GRRMF (2.19B) vs IDTA (1.62M).
GRRMFIDTAGRRMF / IDTA
Capitalization1.75B809K215,698%
EBITDA422M517K81,625%
Gain YTD-26.294-46.55356%
P/E Ratio24.151.941,244%
Revenue2.19B1.62M135,396%
Total Cash203M203K100,000%
Total Debt2.21B650K339,385%
FUNDAMENTALS RATINGS
GRRMF vs IDTA: Fundamental Ratings
GRRMF
IDTA
OUTLOOK RATING
1..100
3490
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
8718
PRICE GROWTH RATING
1..100
8865
P/E GROWTH RATING
1..100
4997
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDTA's Valuation (38) in the null industry is in the same range as GRRMF (56). This means that IDTA’s stock grew similarly to GRRMF’s over the last 12 months.

IDTA's Profit vs Risk Rating (97) in the null industry is in the same range as GRRMF (100). This means that IDTA’s stock grew similarly to GRRMF’s over the last 12 months.

IDTA's SMR Rating (18) in the null industry is significantly better than the same rating for GRRMF (87). This means that IDTA’s stock grew significantly faster than GRRMF’s over the last 12 months.

IDTA's Price Growth Rating (65) in the null industry is in the same range as GRRMF (88). This means that IDTA’s stock grew similarly to GRRMF’s over the last 12 months.

GRRMF's P/E Growth Rating (49) in the null industry is somewhat better than the same rating for IDTA (97). This means that GRRMF’s stock grew somewhat faster than IDTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GRRMFIDTA
RSI
ODDS (%)
Bullish Trend 2 days ago
33%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
20%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
36%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
36%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
31%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
39%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
N/A
Bullish Trend 16 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
30%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GRRMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHB32.440.60
+1.88%
Bar Harbor Bankshares
RS294.965.12
+1.77%
Reliance
ASH54.240.08
+0.15%
Ashland
ALAR14.20-0.19
-1.32%
Alarum Technologies Ltd
KXIN0.60-0.04
-6.72%
Kaixin Holdings

GRRMF and

Correlation & Price change

A.I.dvisor tells us that GRRMF and SAFLF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRRMF and SAFLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRRMF
1D Price
Change %
GRRMF100%
N/A
SAFLF - GRRMF
24%
Poorly correlated
N/A
CYDX - GRRMF
23%
Poorly correlated
N/A
IDTA - GRRMF
7%
Poorly correlated
N/A
GNNDY - GRRMF
5%
Poorly correlated
+0.03%
GTHP - GRRMF
3%
Poorly correlated
+8.53%
More

IDTA and

Correlation & Price change

A.I.dvisor tells us that IDTA and STSS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDTA and STSS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDTA
1D Price
Change %
IDTA100%
N/A
STSS - IDTA
32%
Poorly correlated
-12.26%
MBGNF - IDTA
30%
Poorly correlated
N/A
SRDX - IDTA
22%
Poorly correlated
-1.88%
LUCY - IDTA
22%
Poorly correlated
-1.32%
CVRX - IDTA
20%
Poorly correlated
-1.53%
More